STADA Extends Appointment Of Hartmut Retzlaff As Chairman Of The Executive Board

(RTTNews) - The Supervisory Board of German pharmaceutical and healthcare company STADA Arzneimittel AG (STDAY.PK, STDAF.PK) Tuesday said it extended the appointment of Hartmut Retzlaff as Chairman of the Executive Board by five years until August 31, 2021.

Retzlaff has been Chairman of the Executive Board at STADA since 1993. His previous contract would have ended on August 31, 2016.

Retzlaff is the Executive Board member responsible for the areas of Marketing and Sales, Corporate Strategy, Corporate Communications,Production, Purchasing and Procurement, Research and Development as well as Biotechnology.

With the appointment, the Executive Board of STADA continues to consist of Hartmut Retzlaff, Chairman of the Executive Board, Helmut Kraft, Chief Financial Officer, and Dr. Matthias Wiedenfels, Chief Business Development & Central Services Officer.